Topical Antibiotics Market
Topical antibiotics have emerged as a popular drug class for the treatment and management of a range of medical conditions. Among different indications such as the skin, eye, and Bromhidrosis, the use of topical antibiotics to fight bacterial skin infection has witnessed consistent growth over the past few decades– a trend that is expected to continue over the upcoming years. Research and development activities around the world are likely to fuel the growth of the global topical antibiotics market, as new topical antibiotics continue to enter the market. While the growing popularity of antiseptics could potentially hinder market growth, the growing awareness pertaining to the benefits of topical antibiotics is anticipated to boost the demand.
At present, drug developers and other stakeholders involved in the global topical antibiotics market are increasingly focusing on addressing various issues related to the use of topical antibiotics, including increasing rate of bacterial resistance and local hypersensitivity. In the current scenario, topical antibiotics are one of the most prescribed antimicrobial agents worldwide. Europe and North America are projected to provide lucrative opportunities to the market players involved in the topical antibiotics market landscape due to a robust healthcare infrastructure in these regions, growing investments for drug development and research, etc.
These factors, along with the growing emphasis on identifying more indications for which topical antibiotics are likely to be effective are expected to propel the growth of the market for the topical antibiotics market during the assessment period. The global topical antibiotics market is anticipated to attain a market value of US$ 8.3 Bn by the end of 2030.
To know the scope of our report Get a Sample on Topical Antibiotics Market
Over the past few decades, the demand for topical antibiotics has witnessed considerable growth at a consistent rate. However, despite the impressive growth rate in terms of adoption, market players are increasingly focusing on addressing the various challenges involved in the use of topical antibiotics. Research and development activities across the topical antibiotics market landscape are projected to primarily focus on improving the clinical efficacy of these drugs. In addition, the entry of new and emerging agents, including ebselen and retapamulin will provide an immense boost to the overall prospects of the global topical antibiotics market during the assessment period. Despite the growing use of topical antibiotics, there is a growing need to address the increasing bacterial resistance among patients in a few settings due to which, the efficacy of these drugs is compromised. In addition, the ecological impact of topical antibiotics is another area of concern due to which, research activities have gained momentum.
Get a glimpse of the in-depth analysis through our Report Brochure
The clinical usage of topical antibiotics, particularly in developed regions of the world is projected to grow at a commendable pace in the upcoming years. However, the Asia Pacific region is expected to provide abundant opportunities for market players during the latter half of the forecast period.
Although skin infections continue to affect millions of individuals around the world, at present, the global healthcare sector is primarily focusing and engaged in curbing the transmission of the novel coronavirus infection. In addition, research and development activities are also aiming at the development of a vaccine. However, the production and development of topical antibiotics are likely to remain unaffected around the world, as drug manufacturers and the pharmaceutical sector are exempted from lockdown measures enforced by governments worldwide.
Although the production is expected to remain unaffected, the demand for topical antibiotics could see a decline amid the COVID-19 pandemic. Although the growth is expected to remain slower than usual, the market is expected to show signs of recovery in the last quarter of 2020.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
The global topical antibiotics market is expected to grow at a sluggish CAGR of ~3% during the forecast period. The market growth can be primarily attributed to a host of factors, including growing focus on improving the efficacy of topical antibiotics, growing investments toward research & development activities, entry of new and emerging topic antibiotics agents, and the considerable surge in the number of skin infections around the world. Market players should focus on addressing challenges put forward by topical antibiotics such as increasing bacterial resistance, catastrophic ecological impact, etc. While North America and Europe are likely to remain at the forefront in terms of market share and value, the Asia Pacific region is projected to provide a safe haven for growth to the market players in the upcoming years.
Topical Antibiotics Market – Segmentation
|
Drug Class |
|
|
Dosage Form |
|
|
Indication |
|
|
Product Type |
|
|
Distribution Channel |
|
|
Region |
|
The global topical antibiotics market was worth US$ 5.8 Bn and is projected to reach a value of US$ 8.3 Bn by the end of 2030
Topical antibiotics market is anticipated to grow at a CAGR of 3% during the forecast period
North America accounted for a major share of the global topical antibiotics market
Topical antibiotics market is driven by increase in incidence rate of dermatological and ophthalmic disorders across the globe and rise in awareness about various skin diseases are projected to drive the market during the forecast period
Key players in the global topical antibiotics market include Novartis AG, GlaxoSmithKline plc, Perrigo Company plc, Pfizer, Inc., Almirall, S.A., Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.), Medimetriks Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd., and Mayne Pharma Group Limited
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global Topical Antibiotics Market: Market Snapshot
4. Market Overview
4.1. Global Topical Antibiotics Market: Type Overview
4.2. Global Topical Antibiotics Market: Key Industry Developments
4.3. Market Dynamics
4.4. Drivers and Restraints Snapshot Analysis
4.5. Drivers
4.6. Restraints
4.7. Opportunities
4.8. Global Topical Antibiotics Market Revenue Projections (US$ Mn), 2018–2030
5. Key Insights
5.1. Prevalence of antibiotic resistance
5.2. Regulatory Scenario by Key Countries
5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
5.4. Key Industry Events (Mergers, Acquisitions, Product Launches, Strategic Partnerships, etc.)
5.5. Total Consumption of Antibiotics (Metric Tones
6. Global Topical Antibiotics Market Analysis, by Drug Class
6.1. Introduction
6.2. Global Topical Antibiotics Market Value and Forecast, by Drug Class
6.2.1. Tetracycline
6.2.2. Aminoglycosides
6.2.3. Erythromycin
6.2.4. Clindamycin
6.2.5. Others
6.3. Global Topical Antibiotics Market Analysis, by Drug Class
6.4. Global Topical Antibiotics Market Attractiveness Analysis, by Drug Class
7. Global Topical Antibiotics Market Analysis, by Dosage Form
7.1. Introduction
7.2. Global Topical Antibiotics Market Value and Forecast, by Dosage Form
7.2.1. Ointments
7.2.2. Creams
7.2.3. Powder
7.2.4. Gels
7.2.5. Others
7.3. Global Topical Antibiotics Market Analysis, by Dosage Form
7.4. Global Topical Antibiotics Market Attractiveness Analysis, by Dosage Form
8. Global Topical Antibiotics Market Analysis, by Indication
8.1. Introduction
8.2. Global Topical Antibiotics Market Value and Forecast, by Indication
8.2.1. Skin Infection
8.2.2. Eye Infection
8.2.3. Bromhidrosis
8.2.4. Others
8.3. Global Topical Antibiotics Market Analysis, by Indication
8.4. Global Topical Antibiotics Market Attractiveness Analysis, by Indication
9. Global Topical Antibiotics Market Analysis, by Product Type
9.1. Introduction
9.2. Global Topical Antibiotics Market Value and Forecast, by Product Type
9.2.1. Prescription
9.2.2. OTC
9.3. Global Topical Antibiotics Market Analysis, by Product Type
9.4. Global Topical Antibiotics Market Attractiveness Analysis, by Product Type
10. Global Topical Antibiotics Market Analysis, by Distribution Channel
10.1. Introduction
10.2. Global Topical Antibiotics Market Value and Forecast, by Distribution Channel
10.2.1. Hospital Pharmacies
10.2.2. Retail Pharmacies
10.2.3. Others
10.3. Global Topical Antibiotics Market Analysis, by Distribution Channel
10.4. Global Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel
11. Global Topical Antibiotics Market Analysis, by Region
11.1. Global Topical Antibiotics Market Value and Forecast, by Region, 2018–2030
11.1.1. North America
11.1.2. Europe
11.1.3. Asia Pacific
11.1.4. Latin America
11.1.5. Middle East & Africa
11.2. Global Topical Antibiotics Market Analysis, by Region
11.3. Global Topical Antibiotics Market Attractiveness Analysis, by Region
12. North America Topical Antibiotics Market Analysis
12.1. North America Topical Antibiotics Market
12.2. North America Topical Antibiotics Market Overview
12.3. North America Topical Antibiotics Market Value and Forecast, by Drug Class
12.3.1. Tetracycline
12.3.2. Aminoglycosides
12.3.3. Erythromycin
12.3.4. Clindamycin
12.3.5. Others
12.4. North America Topical Antibiotics Market Value and Forecast, by Dosage Form
12.4.1. Ointments
12.4.2. Creams
12.4.3. Powder
12.4.4. Gels
12.4.5. Others
12.5. North America Topical Antibiotics Market Value and Forecast, by Indication
12.5.1. Skin Infection
12.5.2. Eye Infection
12.5.3. Bromhidrosis
12.5.4. Others
12.6. North America Topical Antibiotics Market Value and Forecast, by Product Type
12.6.1. Prescription
12.6.2. OTC
12.7. North America Topical Antibiotics Market Value and Forecast, by Distribution Channel
12.7.1. Hospital Pharmacies
12.7.2. Retail Pharmacies
12.7.3. Others
12.8. North America Topical Antibiotics Market Forecast, by Country
12.8.1. U.S.
12.8.2. Canada
12.9. North America Topical Antibiotics Market Attractiveness Analysis
12.9.1. By Product Type
12.9.2. By Application
12.9.3. By Distribution Channel
12.9.4. By Country
13. Europe Topical Antibiotics Market Analysis
13.1. Europe Topical Antibiotics Market
13.2. Europe Topical Antibiotics Market Overview
13.3. Europe Topical Antibiotics Market Value and Forecast, by Drug Class
13.3.1. Tetracycline
13.3.2. Aminoglycosides
13.3.3. Erythromycin
13.3.4. Clindamycin
13.3.5. Others
13.4. Europe Topical Antibiotics Market Value and Forecast, by Dosage Form
13.4.1. Ointments
13.4.2. Creams
13.4.3. Powder
13.4.4. Gels
13.4.5. Others
13.5. Europe Topical Antibiotics Market Value and Forecast, by Indication
13.5.1. Skin Infection
13.5.2. Eye Infection
13.5.3. Bromhidrosis
13.5.4. Others
13.6. Europe Topical Antibiotics Market Value and Forecast, by Product Type
13.6.1. Prescription
13.6.2. OTC
13.7. Europe Topical Antibiotics Market Value and Forecast, by Distribution Channel
13.7.1. Hospital Pharmacies
13.7.2. Retail Pharmacies
13.7.3. Others
13.8. Europe Topical Antibiotics Market Forecast, by Country/Sub-region
13.8.1. U.K.
13.8.2. France
13.8.3. Germany
13.8.4. Spain
13.8.5. Italy
13.8.6. Rest of Europe
13.9. Europe Topical Antibiotics Market Attractiveness Analysis
13.9.1. By Product Type
13.9.2. By Application
13.9.3. By Route of Administration
13.9.4. By Distribution Channel
13.9.5. By Country/Sub-region
14. Asia Pacific Topical Antibiotics Market Analysis
14.1. Asia Pacific Topical Antibiotics Market
14.2. Asia Pacific Topical Antibiotics Market Overview
14.3. Asia Pacific Topical Antibiotics Market Value and Forecast, by Drug Class
14.3.1. Tetracycline
14.3.2. Aminoglycosides
14.3.3. Erythromycin
14.3.4. Clindamycin
14.3.5. Others
14.4. Asia Pacific Topical Antibiotics Market Value and Forecast, by Dosage Form
14.4.1. Ointments
14.4.2. Creams
14.4.3. Powder
14.4.4. Gels
14.4.5. Others
14.5. Asia Pacific Topical Antibiotics Market Value and Forecast, by Indication
14.5.1. Skin Infection
14.5.2. Eye Infection
14.5.3. Bromhidrosis
14.5.4. Others
14.6. Asia Pacific Topical Antibiotics Market Value and Forecast, by Product Type
14.6.1. Prescription
14.6.2. OTC
14.7. Asia Pacific Topical Antibiotics Market Value and Forecast, by Distribution Channel
14.7.1. Hospital Pharmacies
14.7.2. Retail Pharmacies
14.7.3. Others
14.8. Asia Pacific Topical Antibiotics Market Forecast, by Country/Sub-region
14.8.1. China
14.8.2. India
14.8.3. Japan
14.8.4. Australia & New Zealand
14.8.5. Rest of Asia Pacific
14.9. Asia Pacific Topical Antibiotics Market Attractiveness Analysis
14.9.1. By Product Type
14.9.2. By Application
14.9.3. By Distribution Channel
14.9.4. By Country/Sub-region
15. Latin America Topical Antibiotics Market Analysis
15.1. Latin America Topical Antibiotics Market
15.2. Latin America Topical Antibiotics Market Overview
15.3. Latin America Topical Antibiotics Market Value and Forecast, by Drug Class
15.3.1. Tetracycline
15.3.2. Aminoglycosides
15.3.3. Erythromycin
15.3.4. Clindamycin
15.3.5. Others
15.4. Latin America Topical Antibiotics Market Value and Forecast, by Dosage Form
15.4.1. Ointments
15.4.2. Creams
15.4.3. Powder
15.4.4. Gels
15.4.5. Others
15.5. Latin America Topical Antibiotics Market Value and Forecast, by Indication
15.5.1. Skin Infection
15.5.2. Eye Infection
15.5.3. Bromhidrosis
15.5.4. Others
15.6. Latin America Topical Antibiotics Market Value and Forecast, by Product Type
15.6.1. Prescription
15.6.2. OTC
15.7. Latin America Topical Antibiotics Market Value and Forecast, by Distribution Channel
15.7.1. Hospital Pharmacies
15.7.2. Retail Pharmacies
15.7.3. Others
15.8. Latin America Topical Antibiotics Market Forecast, by Country/Sub-region
15.8.1. Brazil
15.8.2. Mexico
15.8.3. Rest of Latin America
15.9. Latin America Topical Antibiotics Market Attractiveness Analysis
15.9.1. By Product Type
15.9.2. By Application
15.9.3. By Distribution Channel
15.9.4. By Country/Sub-region
16. Middle East & Africa Topical Antibiotics Market Analysis
16.1. Middle East & Africa Topical Antibiotics Market
16.2. Middle East & Africa Topical Antibiotics Market Overview
16.3. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Drug Class
16.3.1. Tetracycline
16.3.2. Aminoglycosides
16.3.3. Erythromycin
16.3.4. Clindamycin
16.3.5. Others
16.4. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Dosage Form
16.4.1. Ointments
16.4.2. Creams
16.4.3. Powder
16.4.4. Gels
16.4.5. Others
16.5. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Indication
16.5.1. Skin Infection
16.5.2. Eye Infection
16.5.3. Bromhidrosis
16.5.4. Others
16.6. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Product Type
16.6.1. Prescription
16.6.2. OTC
16.7. Middle East & Africa Topical Antibiotics Market Value and Forecast, by Distribution Channel
16.7.1. Hospital Pharmacies
16.7.2. Retail Pharmacies
16.7.3. Others
16.8. Middle East & Africa Topical Antibiotics Market Forecast, by Country/Sub-region
16.8.1. GCC Countries
16.8.2. South Africa
16.8.3. Rest of Middle East & Africa
16.9. Middle East & Africa Topical Antibiotics Market Attractiveness Analysis
16.9.1. By Product Type
16.9.2. By Application
16.9.3. By Distribution Channel
16.9.4. By Country/Sub-region
17. Competitive Landscape
17.1. Company Profiles
17.1.1. Novartis AG
17.1.1.1. Overview (HQ, Employee Strength, Business Segments)
17.1.1.2. Financials
17.1.1.3. Recent Developments
17.1.1.4. Strategy
17.1.2. GlaxoSmithKline plc
17.1.2.1. Overview (HQ, Employee Strength, Business Segments)
17.1.2.2. Financials
17.1.2.3. Recent Developments
17.1.2.4. Strategy
17.1.3. Perrigo Company plc
17.1.3.1. Overview (HQ, Employee Strength, Business Segments)
17.1.3.2. Financials
17.1.3.3. Recent Developments
17.1.3.4. Strategy
17.1.4. Pfizer, Inc.
17.1.4.1. Overview (HQ, Employee Strength, Business Segments)
17.1.4.2. Financials
17.1.4.3. Recent Developments
17.1.4.4. Strategy
17.1.5. Almirall, S.A.
17.1.5.1. Overview (HQ, Employee Strength, Business Segments)
17.1.5.2. Financials
17.1.5.3. Recent Developments
17.1.5.4. Strategy
17.1.6. Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
17.1.6.1. Overview (HQ, Employee Strength, Business Segments)
17.1.6.2. Financials
17.1.6.3. Recent Developments
17.1.6.4. Strategy
17.1.7. Medimetriks Pharmaceuticals, Inc.
17.1.7.1. Overview (HQ, Employee Strength, Business Segments)
17.1.7.2. Financials
17.1.7.3. Recent Developments
17.1.7.4. Strategy
17.1.8. Taro Pharmaceutical Industries Ltd.
17.1.8.1. Overview (HQ, Employee Strength, Business Segments)
17.1.8.2. Financials
17.1.8.3. Recent Developments
17.1.8.4. Strategy
17.1.9. Mayne Pharma Group Limited
17.1.9.1. Overview (HQ, Employee Strength, Business Segments)
17.1.9.2. Financials
17.1.9.3. Recent Developments
17.1.9.4. Strategy
List of Tables
TABLE 1 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
TABLE 2 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
TABLE 3 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication, 2018–2030
TABLE 4 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
TABLE 5 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
TABLE 6 Global Topical Antibiotics Market Value (US$ Mn) Forecast, by Region, 2018–2030
TABLE 7 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Country, 2018–2030
TABLE 8 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
TABLE 9 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
TABLE 10 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication, 2018–2030
TABLE 11 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
TABLE 12 North America Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
TABLE 13 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
TABLE 14 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class 2018–2030
TABLE 15 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
TABLE 16 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication 2018–2030
TABLE 17 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type2018–2030
TABLE 18 Europe Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel 2018–2030
TABLE 19 Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
TABLE 20 Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
TABLE 21 Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
TABLE 22 Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Indication, 2018–2030
TABLE 23 Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2018–2030
TABLE 24 Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2030
TABLE 25 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
TABLE 26 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
TABLE 27 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
TABLE 28 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication, 2018–2030
TABLE 29 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
TABLE 30 Latin America Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
TABLE 31 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
TABLE 32 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
TABLE 33 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
TABLE 34 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Indication, 2018–2030
TABLE 35 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
TABLE 36 Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
List of Figures
Figure 1: Global Topical Antibiotics Market Value (US$ Mn) Forecast, 2018–2030
Figure 2: Global Topical Antibiotics Market, by Drug Class, 2019
Figure 3: Global Topical Antibiotics Market Value Share, by Dosage Form, 2019
Figure 4: Global Topical Antibiotics Market Value Share, by Indication, 2019
Figure 5: Global Topical Antibiotics Market, by Product Type, 2019
Figure 6: Global Topical Antibiotics Market Value Share, by Region, 2019
Figure 7: Global Topical Antibiotics Market Value Share, by Distribution Channel, 2019
Figure 8: Global Topical Antibiotics Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 9: Global Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2020-2030
Figure 10: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Tetracycline, 2018–2030
Figure 11: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Aminoglycosides, 2018–2030
Figure 12: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Erythromycin, 2018–2030
Figure 13: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Clindamycin, 2018–2030
Figure 14: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018–2030
Figure 15: Global Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 16: North America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 17: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Ointments, 2018–2030
Figure 18: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Creams, 2018–2030
Figure 19: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Powder, 2018–2030
Figure 20: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Gels, 2018–2030
Figure 21: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018–2030
Figure 22: Global Topical Antibiotics Market Value Share Analysis, by Indication, 2019 and 2030
Figure 23: Global Topical Antibiotics Market Attractiveness Analysis, by Indication, 2020–2030
Figure 24: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Skin Infection, 2018–2030
Figure 25: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Eye Infection, 2018–2030
Figure 26: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Bromhidrosis, 2018–2030
Figure 27: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018–2030
Figure 28: Global Topical Antibiotics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 29: Global Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 30: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Prescription, 2018–2030
Figure 31: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by OTC, 2018–2030
Figure 32: Global Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 33: Global Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 34: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospital Pharmacies, 2018–2030
Figure 35: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Retail Pharmacies, 2018–2030
Figure 36: Global Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018–2030
Figure 37: Global Topical Antibiotics Market Value Share Analysis, by Region, 2019 and 2030
Figure 38: Global Topical Antibiotics Market Attractiveness Analysis, by Region, 2020–2030
Figure 39: North America Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2018–2030
Figure 40: North America Topical Antibiotics Market Value Share Analysis, by Country, 2019 and 2030
Figure 41: North America Topical Antibiotics Market Attractiveness Analysis, by Country, 2020–2030
Figure 42: North America Topical Antibiotics Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 43: North America Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 44: North America Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 45: North America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 46: North America Topical Antibiotics Market Value Share Analysis, by Indication, 2019 and 2030
Figure 47: North America Topical Antibiotics Market Attractiveness Analysis, by Indication, 2020–2030
Figure 48: North America Topical Antibiotics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 49: North America Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 50: North America Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 51: North America Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 52: Europe Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2018–2030
Figure 53: Europe Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 54: Europe Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 55: Europe Topical Antibiotics Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 56: Europe Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 57: Europe Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 58: Europe Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 59: Europe Topical Antibiotics Market Value Share Analysis, by Indication, 2019 and 2030
Figure 60: Europe Topical Antibiotics Market Attractiveness Analysis, by Indication, 2020–2030
Figure 61: Europe Topical Antibiotics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 62: Europe Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 63: Europe Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 64: Europe Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 65: Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2018–2030
Figure 66: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 67: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 68: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 69: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 70: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 71: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 72: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Indication, 2019 and 2030
Figure 73: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Indication, 2020–2030
Figure 74: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 75: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 76: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 77: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 78: Latin America Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2018–2030
Figure 79: Latin America Topical Antibiotics Market Value Share, by Country/Sub-region, 2019 and 2030
Figure 80: Latin America Topical Antibiotics Market Attractiveness, by Country/Sub-region, 2020–2030
Figure 81: Latin America Topical Antibiotics Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 82: Latin America Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 83: Latin America Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 84: Latin America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 85: Latin America Topical Antibiotics Market Value Share Analysis, by Indication, 2019 and 2030
Figure 86: Latin America Topical Antibiotics Market Attractiveness Analysis, by Indication, 2020–2030
Figure 87: Latin America Topical Antibiotics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 88: Latin America Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 89: Latin America Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 90: Latin America Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 91: Middle East & Africa Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2018–2030
Figure 92: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 93: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 94: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 95: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 96: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 97: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 98: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Indication, 2019 and 2030
Figure 99: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Indication, 2020–2030
Figure 100: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 101: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 102: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 103: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes